Trisenox and dyspnoea Patient Reports February 13, 2012

Trisenox Side Effects Report #5853357-9
Trisenox side effect was reported by a Health Professional from ITALY on Apr 26, 2007. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, atrial fibrillation , atrial flutter, cardiac failure congestive, dyspnoea, left ventricular hypertrophy, lung consolidation, mitral valve incompetence, pericardial effusion. Trisenox dosage: unknown. During the same period patient was treated with MAG, CALCIUM SANDOZ, ASPIRIN, GLIBOMET, OMEPRAZOLE, HUMALOG. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5853398-1
Trisenox side effect was reported by a Physician from ITALY on Aug 09, 2006. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cachexia, disease progression, dyspnoea, myelodysplastic syndrome. Trisenox dosage: 21 MG TWICE WEEKLY INTRAVENOUS DRIP. During the same period patient was treated with ASCORBIC ACID, PURINETHOL, VINCRISTINE. Patient died on 07/25/2006.

Trisenox Side Effects Report #5919002-9
Trisenox side effect was reported by a Physician from ITALY on Oct 01, 2008. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cachexia, disease progression, dyspnoea. Trisenox dosage: 21 MG TWICE WEEKLY INTRAVENOUS DRIP. During the same period patient was treated with ASCORBIC ACID, PURINETHOL, VINCRISTINE, MORPHINE. Patient died on 07/25/2006.

Trisenox Side Effects Report #5926588-7
Trisenox side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cachexia, disease progression, dyspnoea, myelodysplastic syndrome. Trisenox dosage: 21 MG TWICE WEEKLY INTRAVENOUS DRIP. During the same period patient was treated with ASCORBIC ACID, PURINETHOL, VINCRISTINE, MORPHINE. Patient died on 07/25/2006.


Trisenox Side Effects Report #4597190-7
Trisenox side effect was reported by a Consumer or non-health professional from on Feb 09, 2005. Female patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, fluid overload. Trisenox dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4831313-7
Trisenox side effect was reported by a Physician from UNITED STATES on Nov 01, 2005. Male patient, 72 years of age, weighting 206.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation , cardiac failure congestive, dyspnoea, electrolyte imbalance, haemoglobin decreased, hypoalbuminaemia, hyponatraemia, hypophosphataemia. Trisenox dosage: 24 MG QD INTRAVENOUS DRIP. During the same period patient was treated with THALOMID, ZOMETA, PROCRIT, PLAVIX, ATENOLOL, NIACIN, POTASSIUM CHLORIDE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4712479-6
Trisenox side effect was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2005. Female patient, 70 years of age, weighting 126.0 lb, was diagnosed with multiple myeloma  and was treated with Trisenox. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, dyspnoea, platelet count decreased, pyrexia, rash , white blood cell count decreased. Trisenox dosage: 14 MG IVI. During the same period patient was treated with MELPHALAN, ASCORBIC ACID, OXYTROL, SANTURA, FOLIC ACID. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #5373417-9
Trisenox side effect was reported by a Pharmacist from UNITED STATES on June 26, 2007. Female patient, weighting 194.0 lb, was diagnosed with ill-defined disorder and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chills, dyspnoea, infusion related reaction, pyrexia. Trisenox dosage: 12.45 MG 5X/WEEK FOR 5 WKS IV. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4569722-6
Trisenox side effect was reported by a Health Professional from on Dec 21, 2004. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: body temperature increased, disseminated intravascular coagulation, dyspnoea, electrocardiogram qt prolonged, leukocytosis, ventricular tachycardia. Trisenox dosage: 0.15MG/KG (QD), INTRAVENOUS. Patient recovered.


Trisenox Side Effects Report #4661118-1
Trisenox side effect was reported by a Physician from on Apr 26, 2005. Male patient, 66 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: body temperature increased, disseminated intravascular coagulation, dyspnoea, electrocardiogram qt corrected interval prolonged, leukocytosis, platelet count decreased, ventricular tachycardia, white blood cell count decreased. Trisenox dosage: unknown. During the same period patient was treated with NAFAMOSTAT, MAGNESIUM SULPHATE. Patient recovered.

Trisenox Side Effects Report #5632251-2
Trisenox side effect was reported by a Physician from JAPAN on Jan 28, 2008. Female patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, dyspnoea, electrocardiogram qt prolonged. Trisenox dosage: 8.85 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, POTASSIUM SUPPLEMENT, GABEXATE MESILATE, CARPERITIDE, MICAFUNGIN. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4678283-2
Trisenox side effect was reported by a Physician from on Dec 27, 2004. Male patient, 55 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, body temperature increased, c-reactive protein increased, constipation , dyspnoea, hypoxia, pleural effusion. Trisenox dosage: 12.3 MG (12.3 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4553545-8
Trisenox side effect was reported by a Health Professional from on Dec 27, 2004. Male patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: c-reactive protein increased, dyspnoea, pleural effusion. Trisenox dosage: 12 MG (12 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Trisenox Side Effects Report #4681113-6
Trisenox side effect was reported by a Physician from on Apr 18, 2005. Female patient was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: arthralgia, back pain , blood potassium decreased, dyspnoea, neuropathy, pain in extremity, weight increased. Trisenox dosage: 0.15 MG/KG (0.15 MG/KG, 5X/WK), IVI. Patient recovered.